J.M. Smucker has signed a definitive agreement to acquire the Hostess brand of products for a total enterprise value of $5.6 billion, including $900 million of net debt.
The U.S. healthcare system, including patients, employers and taxpayers, saved $408 billion in 2022 by using FDA-approved generic and biosimilar drugs, per the AAM's report.
The proposed settlement, which needs court approval, will provide consumers who participated in the lawsuit with “approximately double their out-of-pocket damages,” according to reports.
